Keyphrases
Protein Kinase Inhibitors
100%
Cheminformatics
100%
Protein Kinase
100%
Binding Data
88%
Polypharmacology
88%
Drug Design
66%
Drug Resistance
66%
Sequence Structure
66%
BCR-ABL Inhibitors
66%
Keap1-Nrf2
66%
Lung Cancer
66%
Target Similarity
66%
Kinase Target
66%
Chemical Library
55%
Kinome
55%
Publicly Available
33%
Molecular Mechanics Force Field
33%
Patient Demographics
33%
Heterogeneous Structure
33%
Informatics
33%
Crizotinib
33%
Inconsistency
33%
Non-small Cell Lung Cancer (NSCLC)
33%
Hydrogen Bonding Interaction
33%
Arenes
33%
Ligand Binding
33%
X-ray Structure
33%
Interaction Type
33%
Co-target
33%
Proton
33%
Resistant mutants
33%
Diverse Data
33%
Chemical Interaction
33%
EGFR mutation
33%
Ligand Design
22%
Personalized Medicine
22%
Data-driven Approach
22%
Binding Site
22%
Binding Properties
22%
Resistance mutations
22%
Targeting Ligands
22%
Statistical Methods
22%
Physiological Environment
22%
Therapeutic Use
22%
Trial-and-error
22%
Drug Repurposing
22%
Structure Information
22%
Devil
22%
New Therapeutics
22%
Targeted Sequencing
22%
Biochemistry, Genetics and Molecular Biology
Protein Kinase
88%
Drug Resistance
88%
Protein-Protein Interaction
66%
Kinase
66%
Phosphotransferase
66%
Synthesis
66%
Epidermal Growth Factor Receptor
66%
Small Molecule
66%
Transcription Factor Nrf2
66%
Screening
33%
Crystal Structure
33%
Ligand Binding
33%
Kinome
22%
Conformation
16%
Principal Component Analysis
16%
Wild Type
16%
In Silico Study
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistance
88%
Protein Kinase
77%
Virtual Screening
66%
Drug Development
66%
Transcription Factor Nrf2
66%
Phosphotransferase Inhibitor
66%
Lung Cancer
66%
Epidermal Growth Factor Receptor
66%
Protein Kinase Inhibitor
44%
Drug Discovery
41%
Repurposing
16%
Phosphotransferase
16%
Binding Site
16%
Therapeutic Use
16%
